Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Resonance Health Ltd ( (AU:RHT) ).
Resonance Health Limited has appointed David Fuller as a director effective 28 April 2026, as disclosed in an Initial Director’s Interest Notice lodged with the ASX. The filing confirms that Fuller currently holds no direct or indirect interests in Resonance Health securities and has no interest in any related contracts, underscoring a neutral starting position in terms of equity alignment and regulatory disclosure obligations.
More about Resonance Health Ltd
Resonance Health Limited is a publicly listed company in the healthcare sector, focused on providing medical imaging and diagnostic solutions. The company’s shares are traded on the ASX, and its governance structure includes a board of directors whose interests in company securities are disclosed in line with Australian corporate regulations.
Average Trading Volume: 371,533
Technical Sentiment Signal: Sell
Current Market Cap: A$20.99M
For a thorough assessment of RHT stock, go to TipRanks’ Stock Analysis page.